The association between oral contraceptive use, bone mineral density and fractures in women aged 50���80 years



      The associations between oral contraceptive (OC) use, bone mineral density (BMD) and the risk of fractures remain controversial.

      Study Design

      A cross-sectional study of 491 women aged 50���80 years was performed. We assessed OC use and fractures by questionnaire, and BMD and vertebral deformity by dual-energy x-ray absorptiometry.


      Ever use of OC was associated with significantly higher BMD at the total body (6%, p<.001) and spine (4%; p=.05) (but not hip) after adjustment for confounders. There was also a significant association between duration of OC use and total body and spine BMD. Use of OCs for 5���10 years was associated with reduced vertebral deformity (adjusted odds ratio 0.46, 95% confidence interval 0.22���0.94).


      Oral contraceptive use and duration were associated with higher total body and spine BMD and a consistent reduction in vertebral deformities, although most associations did not reach significance.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Contraception
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Caliri A.
        • De Filippis L.
        • Bagnato G.L.
        • Bagnato G.F.
        Osteoporotic fractures: mortality and quality of life.
        Panminerva Med. 2007; 49: 21-27
        • Riggs B.L.
        • Khosla S.
        • Melton III, L.J.
        Sex steroids and the construction and conservation of the adult skeleton.
        Endocr Rev. 2002; 23: 279-302
        • Imai Y.
        • Youn M.Y.
        • Kondoh S.
        • et al.
        Estrogens maintain bone mass by regulating expression of genes controlling function and life span in mature osteoclasts.
        Ann N Y Acad Sci. 2009; 1173: E31-E39
        • Greenwald M.W.
        • Gluck O.S.
        • Lang E.
        • Rakov V.
        Oral hormone therapy with 17beta-estradiol and 17beta-estradiol in combination with norethindrone acetate in the prevention of bone loss in early postmenopausal women: dose-dependent effects.
        Menopause. 2005; 12: 741-748
        • Heikkinen J.
        • Vaheri R.
        • Haapalahti J.
        • Timonen U.
        A 10-year follow-up of the effect of continuous-combined hormone replacement therapy and its discontinuation on bone in postmenopausal women.
        Menopause Int. 2008; 14: 70-77
        • Komulainen M.H.
        • Kroger H.
        • Tuppurainen M.T.
        • et al.
        HRT and vit D in prevention of non-vertebral fractures in postmenopausal women; a 5 year randomized trial.
        Maturitas. 2008; 61: 85-94
        • Pasco J.A.
        • Kotowicz M.A.
        • Henry M.J.
        • Panahi S.
        • Seeman E.
        • Nicholson G.C.
        Oral contraceptives and bone mineral density: a population-based study.
        Am J Obstet Gynecol. 2000; 182: 265-269
        • Cromer B.A.
        Bone mineral density in adolescent and young adult women on injectable or oral contraception.
        Curr Opin Obstet Gynecol. 2003; 15: 353-357
        • Wei S.
        • Jones G.
        • Thomson R.
        • Dwyer T.
        • Venn A.
        Oral contraceptive use and bone mass in women aged 26���36 years.
        Osteoporos Int. 2011; 22: 351-355
        • Berenson A.B.
        • Breitkopf C.R.
        • Grady J.J.
        • Rickert V.I.
        • Thomas A.
        Effects of hormonal contraception on bone mineral density after 24 months of use.
        Obstet Gynecol. 2004; 103: 899-906
        • Wei S.
        • Winzenberg T.
        • Laslett L.L.
        • Venn A.
        • Jones G.
        Oral contraceptive use and bone.
        Curr Osteoporos Rep. 2011; 9: 6-11
        • Gambacciani M.
        • Cappagli B.
        • Lazzarini V.
        • Ciaponi M.
        • Fruzzetti F.
        • Genazzani A.R.
        Longitudinal evaluation of perimenopausal bone loss: effects of different low dose oral contraceptive preparations on bone mineral density.
        Maturitas. 2006; 54: 176-180
        • Reed S.D.
        • Scholes D.
        • LaCroix A.Z.
        • Ichikawa L.E.
        • Barlow W.E.
        • Ott S.M.
        Longitudinal changes in bone density in relation to oral contraceptive use.
        Contraception. 2003; 68: 177-182
        • Nappi C.
        • Di Spiezio Sardo A.
        • Greco E.
        • Tommaselli G.A.
        • Giordano E.
        • Guida M.
        Effects of an oral contraceptive containing drospirenone on bone turnover and bone mineral density.
        Obstet Gynecol. 2005; 105: 53-60
        • Lopez L.M.
        • Grimes D.A.
        • Schulz K.F.
        • Curtis K.M.
        Steroidal contraceptives: effect on bone fractures in women.
        Cochrane Database Syst Rev. 2009; : CD006033
        • Delmas P.D.
        • Genant H.K.
        • Crans G.G.
        • et al.
        Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial.
        Bone. 2003; 33: 522-532
        • Haentjens P.
        • Autier P.
        • Collins J.
        • Velkeniers B.
        • Vanderschueren D.
        • Boonen S.
        Colles fracture, spine fracture, and subsequent risk of hip fracture in men and women. A meta-analysis.
        J Bone Joint Surg Am. 2003; 85-A: 1936-1943
        • Black D.M.
        • Arden N.K.
        • Palermo L.
        • Pearson J.
        • Cummings S.R.
        Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group.
        J Bone Miner Res. 1999; 14: 821-828
        • Pongchaiyakul C.
        • Nguyen N.D.
        • Jones G.
        • Center J.R.
        • Eisman J.A.
        • Nguyen T.V.
        Asymptomatic vertebral deformity as a major risk factor for subsequent fractures and mortality: a long-term prospective study.
        J Bone Miner Res. 2005; 20: 1349-1355
        • Vestergaard P.
        • Rejnmark L.
        • Mosekilde L.
        Oral contraceptive use and risk of fractures.
        Contraception. 2006; 73: 571-576
        • O'Neill T.W.
        • Silman A.J.
        • Naves Diaz M.
        • Cooper C.
        • Kanis J.
        • Felsenberg D.
        Influence of hormonal and reproductive factors on the risk of vertebral deformity in European women. European Vertebral Osteoporosis Study Group.
        Osteoporos Int. 1997; 7: 72-78
        • Roy D.K.
        • O'Neill T.W.
        • Finn J.D.
        • et al.
        Determinants of incident vertebral fracture in men and women: results from the European Prospective Osteoporosis Study (EPOS).
        Osteoporos Int. 2003; 14: 19-26
        • Ireland P.J.D.
        • Giles G.
        • O'Dea K.
        • et al.
        Development of the Melbourne FFQ: a food frequency questionnaire for use in an Australian prospective study involving an ethnically diverse cohort.
        Asia Pac J Clin Nutr. 1994; 3: 19-31
        • Australia M.I.M.S.
        MIMS annual.
        33rd ed. CMPMedica, St Leonards NSW2009
        • Cobb K.L.
        • Kelsey J.L.
        • Sidney S.
        • Ettinger B.
        • Lewis C.E.
        Oral contraceptives and bone mineral density in white and black women in CARDIA. Coronary Risk Development in Young Adults.
        Osteoporos Int. 2002; 13: 893-900
        • Lloyd T.
        • Petit M.A.
        • Lin H.M.
        • Beck T.J.
        Lifestyle factors and the development of bone mass and bone strength in young women.
        J Pediatr. 2004; 144: 776-782
        • Almstedt Shoepe H.
        • Snow C.M.
        Oral contraceptive use in young women is associated with lower bone mineral density than that of controls.
        Osteoporos Int. 2005; 16: 1538-1544
        • Ruffing J.A.
        • Nieves J.W.
        • Zion M.
        • et al.
        The influence of lifestyle, menstrual function and oral contraceptive use on bone mass and size in female military cadets.
        Nutr Metab (Lond). 2007; 4: 17
        • Hartard M.
        • Kleinmond C.
        • Wiseman M.
        • Weissenbacher E.R.
        • Felsenberg D.
        • Erben R.G.
        Detrimental effect of oral contraceptives on parameters of bone mass and geometry in a cohort of 248 young women.
        Bone. 2007; 40: 444-450
        • Kleerekoper M.
        • Brienza R.S.
        • Schultz L.R.
        • Johnson C.C.
        Oral contraceptive use may protect against low bone mass. Henry Ford Hospital Osteoporosis Cooperative Research Group.
        Arch Intern Med. 1991; 151: 1971-1976
        • Masaryk P.
        • Lunt M.
        • Benevolenskaya L.
        • et al.
        Effects of menstrual history and use of medications on bone mineral density: the EVOS Study.
        Calcif Tissue Int. 1998; 63: 271-276
        • Kritz-Silverstein D.
        • Barrett-Connor E.
        Bone mineral density in postmenopausal women as determined by prior oral contraceptive use.
        Am J Public Health. 1993; 83: 100-102
        • Progetto Menopausa Italia Study Group
        Risk of low bone density in women attending menopause clinics in Italy.
        Maturitas. 2002; 42: 105-111
        • Sultana S.
        • Choudhury S.
        • Choudhury S.A.
        Effect of combined oral contraceptives on bone mineral density in pre and postmenopausal women.
        Mymensingh Med J. 2002; 11: 12-14
        • Woodson G.C.
        Risk factors for osteoporosis in postmenopausal African���American women.
        Curr Med Res Opin. 2004; 20: 1681-1687
        • Cauley J.A.
        • Robbins J.
        • Chen Z.
        • et al.
        Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.
        JAMA. 2003; 290: 1729-1738
        • Murphy S.
        • Khaw K.T.
        • Compston J.E.
        Lack of relationship between hip and spine bone mineral density and oral contraceptive use.
        Eur J Clin Invest. 1993; 23: 108-111
        • Melton III, L.J.
        • Bryant S.C.
        • Wahner H.W.
        • et al.
        Influence of breastfeeding and other reproductive factors on bone mass later in life.
        Osteoporos Int. 1993; 3: 76-83
        • Hassa H.
        • Tanir H.M.
        • Senses T.
        • Oge T.
        • Sahin-Mutlu F.
        Related factors in bone mineral density of lumbal and femur in natural postmenopausal women.
        Arch Gynecol Obstet. 2005; 273: 86-89
        • Grainge M.J.
        • Coupland C.A.
        • Cliffe S.J.
        • Chilvers C.E.
        • Hosking D.J.
        Reproductive, menstrual and menopausal factors: which are associated with bone mineral density in early postmenopausal women?.
        Osteoporos Int. 2001; 12: 777-787
        • Allali F.
        • El Mansouri L.
        • Abourazzak F.
        • et al.
        The effect of past use of oral contraceptive on bone mineral density, bone biochemical markers and muscle strength in healthy pre and post menopausal women.
        BMC Womens Health. 2009; 9: 31
        • Dhuper S.
        • Warren M.P.
        • Brooks-Gunn J.
        • Fox R.
        Effects of hormonal status on bone density in adolescent girls.
        J Clin Endocrinol Metab. 1990; 71: 1083-1088
        • Buchanan J.R.
        • Myers C.
        • Lloyd T.
        • Leuenberger P.
        • Demers L.M.
        Determinants of peak trabecular bone density in women: the role of androgens, estrogen, and exercise.
        J Bone Miner Res. 1988; 3: 673-680
        • Liu S.L.
        • Lebrun C.M.
        Effect of oral contraceptives and hormone replacement therapy on bone mineral density in premenopausal and perimenopausal women: a systematic review.
        Br J Sports Med. 2006; 40: 11-24
        • Michaelsson K.
        • Baron J.A.
        • Farahmand B.Y.
        • Persson I.
        • Ljunghall S.
        Oral-contraceptive use and risk of hip fracture: a case���control study.
        Lancet. 1999; 353: 1481-1484